Not Yet RecruitingNot Applicable

Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer

China200 participantsStarted 2025-09-15

Plain-language summary

This study was designed as a single-center retrospective analysis aimed at investigating whether COVID-19 infection increases the risk or burden of radiation-induced pneumonitis in breast cancer patients.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. patients with pathologically or cytologically confirmed primary breast cancer,
✓. aged 18 years or older but younger than 80 years,
✓. with complete and reliable medical records,
✓. for those with COVID-19 infection, documented evidence of a positive test result.

Exclusion criteria

✕. concomitant pulmonary malignancies,
✕. a history of prior thoracic radiotherapy,
✕. concurrent pulmonary infections other than COVID-19 during radiotherapy,
✕. missing key data with loss to follow-up,
✕. or any other condition considered unsuitable for enrollment by the investigators.

What they're measuring

Radiation Pneumonitis Situation

Timeframe: From January 2021 to June 2024

Trial details

NCT IDNCT07188116

SponsorZhejiang Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-31

Contact for this trial

Pengyuan Liu

18368846455 oncologyliupengyuan@outlook.com

View on ClinicalTrials.gov More Breast Cancer trials